Trimodal therapy in T2‐4aN0M0 bladder cancer––How to select the best candidate?

The reported results of trimodal treatment (TMT) in muscle‐invasive bladder cancer vary widely. We attempted to characterize the profile of ideal candidates for this approach. Between 2000 and 2019, 105 patients (median age 78 years) with T2‐4aN0M0 bladder cancer were treated with TMT and analyzed r...

Descripción completa

Detalles Bibliográficos
Autores principales: Gofrit, Ofer N., Meirovitz, Amichay, Frank, Stephen, Rabinovich, Igal, Luwisch, Hemda, Yutkin, Vladimir, Neuman, Tzahi, Hidas, Guy, Duvdevani, Mordechai, Wygoda, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666756/
https://www.ncbi.nlm.nih.gov/pubmed/32960495
http://dx.doi.org/10.1002/cam4.3478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666756/
https://www.ncbi.nlm.nih.gov/pubmed/32960495
http://dx.doi.org/10.1002/cam4.3478

Ejemplares similares